32 results
8-K
EX-10.10
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
.
(a) Termination Due To Executive's Death or Disability. In the event Executive's employment with BioZone is terminated due to his death or disability … and unpaid Base Salary through the date of death or date of termination of Executive's employment by BioZone ("Termination Date") for disability, payable
8-K
EX-10.9
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
with BioZone's applicable policies.
10. TERMINATION OF EMPLOYMENT.
(a) Termination Due To Executive's Death or Disability. In the event Executive's … employment with BioZone is terminated due to his death or disability, Executive, his estate or his beneficiaries, as the case may be, shall
8-K
EX-10.8
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
To Executive's Death or Disability. In the event Executive's employment with BioZone is terminated due to his death or disability, Executive, his estate or his … through the date of death or date of termination of Executive's employment by BioZone ("Termination Date") for disability, payable in a cash lump sum
8-K
EX-10.1
COCP
Cocrystal Pharma Inc
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
as a result of incapacity due to mental or physical illness.
(b) DEATH. Automatically on the date of death of the Executive.
(c) CAUSE. Immediately upon … ) years after the Effective Date of an involuntary termination without Cause and other than due to death or Disability.
(e) GOOD REASON. “Good Reason
S-8
EX-10.1
COCP
Cocrystal Pharma Inc
11 May 18
Registration of securities for employees
4:16pm
, as it may be amended from time to time.
1.30. “Retirement” shall mean the termination of the employment, other than for Cause or due to death … .Termination of Employment Due to Death. Subject to the terms of the Plan, any written agreement between the Participant and the Company
8-K
EX-10.2
podpa4z kut5yt1mo20
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
S-8
EX-10.1
p1ty4v1
2 Jan 14
Registration of securities for employees
12:00am
8-K
EX-4.1
el8yzxehxb5oiqlr0ic8
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.6
5l8c 15ps70lxcz1
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.4
54z8zl 3a6tue3xfbo8
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
a2cwn noss
19 Feb 21
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
EX-99.1
bhl7 bxc0vg11hy5k97
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am